+86-15169331170    sales@kimachemical.com
Home / News / Enhancing Drug Delivery with Carboxy Methyl Cellulose-based Nanoparticles

Enhancing Drug Delivery with Carboxy Methyl Cellulose-based Nanoparticles

Views: 0     Author: Site Editor     Publish Time: 2023-09-25      Origin: Site


Nanotechnology has revolutionized the field of drug delivery by offering a platform for the development of nanoscale carriers that can improve the pharmacokinetics and pharmacodynamics of drugs. Among the most promising nanocarriers, polymer-based nanoparticles have emerged as effective delivery systems for drugs. These carriers offer numerous advantages such as controlled release, improved stability, and enhanced targeting efficiency. Carboxy methyl cellulose (CMC) is a polymer that has demonstrated potential as a base material for the development of nanoparticles for drug delivery. This review discusses the potential of CMC-based nanoparticles for drug delivery and highlights their potential advantages over other nanocarriers.

Classification and Synthesis of CMC-Based Nanoparticles

CMC is a polysaccharide that is derived from cellulose. CMC is comprised of carboxymethyl groups, which are attached to its anhydroglucose units via ether linkages. CMC proliferation has been an important research topic due to its excellent properties as a natural polymer. CMC-based nanoparticles can be divided into two categories based on their synthesis method: chemical and physical methods.

Chemical methods involve the synthesis of CMC-based nanoparticles using chemical agents such as crosslinkers, initiators, and stabilizers. Chemical cross-linking typically involves the use of agents such as glutaraldehyde, epichlorohydrin, and formaldehyde to covalently link CMC chains. This method produces nanoparticles with a consistent and controllable particle size distribution, which can be tuned by adjusting the concentration of the cross-linking agent, reaction temperature, and pH. However, cross-linking may result in toxic by-products, which can negatively impact the safety and biocompatibility of the nanoparticles.

Physical methods of CMC-based nanoparticle synthesis are solvent evaporation, emulsion, and self-assembly. Solvent evaporation involves the dissolution of CMC in a water-miscible organic solvent, which is then added to an aqueous solution that contains a surfactant. The emulsion method involves the formation of an oil-in-water (O/W) emulsion, which is stabilized by CMC molecules. Self-assembly is a bottom-up approach that allows the formation of nanoparticles via molecular aggregation or assembly. Physical methods offer a controlled method of nanoparticle synthesis that is free from the need for harsh chemical reagents.

Advantages of CMC-Based Nanoparticles

CMC-based nanoparticles have numerous advantages over other nanocarriers for drug delivery. These advantages include:

1. Cost-Effective and Biocompatible: CMC is a natural polymer that can be derived economically on an industrial scale. CMC is also biocompatible, non-toxic, and non-immunogenic, which makes it an excellent material for biomedical applications.

2. Versatile: CMC can be functionalized with various molecules such as targeting agents, imaging agents, and other biomolecules to improve the efficiency of drug delivery.

3. Stability: CMC-based nanoparticles have high stability in biological environments and can maintain their integrity for extended periods, which ensures controlled drug release kinetics.

4. Targeting Efficiency: CMC-based nanoparticles can be functionalized with targeting agents that can help to improve targeting efficiency and reduce off-target effects.

5. Controlled Release: CMC-based nanoparticles can be tailored to control drug release kinetics and ensure a sustained release of the drug over a desired period.

Applications of CMC-Based Nanoparticles

CMC-based nanoparticles have been studied extensively for their potential in various biomedical applications. These applications include:

1. Cancer Therapy: CMC-based nanoparticles can be functionalized with anti-cancer drugs such as doxorubicin to improve the bioavailability of the drug and enhance targeting efficiency. CMC-based nanoparticles have demonstrated potential in the treatment of breast cancer, lung cancer, and pancreatic cancer.

2. Gene Delivery: CMC-based nanoparticles have been used to deliver small interfering RNA (siRNA) and plasmid DNA (pDNA) for gene therapy applications. The modification of CMC-based nanoparticles with cationic polymers or lipids can help to improve their efficiency in gene delivery.

3. Wound Healing: CMC-based nanoparticles have been examined for their potential in wound healing applications. CMC-based nanoparticles can function as a scaffold for wound healing and encapsulate growth factors to enhance tissue regeneration.

4. Ocular Drug Delivery: CMC-based nanoparticles have been used for ocular drug delivery as they provide controlled release and improved efficacy for treating ocular diseases such as age-related macular degeneration and diabetic retinopathy.


In conclusion, CMC-based nanoparticles offer numerous advantages over other nanocarriers for drug delivery. CMC is a natural polymer that is cost-effective, biocompatible, and non-toxic, making it an attractive material for biomedical applications. The synthesis of CMC-based nanoparticles can be achieved using chemical or physical methods, allowing for controlled and consistent nanoparticle size and morphology. CMC-based nanoparticles have applications in cancer therapy, gene delivery, wound healing, and ocular drug delivery. Therefore, CMC-based nanoparticles have the potential to become a promising platform technology for drug delivery in the future.